PW Medtech Group Limited (HKG:1358)
1.130
+0.060 (5.61%)
Jun 13, 2025, 4:08 PM HKT
PW Medtech Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Revenue | 768.9 | 675.08 | 536.83 | 271.4 | 247.35 | Upgrade
|
Revenue Growth (YoY) | 13.90% | 25.75% | 97.80% | 9.72% | -31.70% | Upgrade
|
Cost of Revenue | 349.46 | 294.19 | 238 | 105.34 | 98.75 | Upgrade
|
Gross Profit | 419.45 | 380.9 | 298.83 | 166.06 | 148.6 | Upgrade
|
Selling, General & Admin | 240.88 | 195.11 | 189.57 | 123.09 | 139.22 | Upgrade
|
Research & Development | 44.12 | 41.13 | 40.98 | 20.25 | 45.77 | Upgrade
|
Other Operating Expenses | -39.55 | -34.48 | -29.89 | -24.35 | -21.46 | Upgrade
|
Operating Expenses | 245.44 | 201.76 | 200.66 | 118.99 | 173.29 | Upgrade
|
Operating Income | 174.01 | 179.14 | 98.17 | 47.07 | -24.69 | Upgrade
|
Interest Expense | -0.37 | -0.15 | -0.46 | -0.61 | -10.67 | Upgrade
|
Interest & Investment Income | 50.65 | 43.83 | 35.37 | 57.34 | 5.55 | Upgrade
|
Earnings From Equity Investments | - | - | - | - | 113.41 | Upgrade
|
Currency Exchange Gain (Loss) | 7.5 | 3.49 | 30.47 | -40.88 | -5.87 | Upgrade
|
EBT Excluding Unusual Items | 231.78 | 226.3 | 163.54 | 62.92 | 77.72 | Upgrade
|
Merger & Restructuring Charges | - | - | -4.8 | -3.92 | - | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | - | - | 552.9 | Upgrade
|
Gain (Loss) on Sale of Assets | -0.11 | -7.14 | -0.01 | 731.79 | -1.53 | Upgrade
|
Asset Writedown | -1.18 | -0.06 | -0.25 | -52.59 | -1.75 | Upgrade
|
Legal Settlements | -0.73 | -0.73 | -0.73 | -0.73 | -0.74 | Upgrade
|
Other Unusual Items | - | 12.7 | - | - | - | Upgrade
|
Pretax Income | 229.75 | 231.07 | 157.75 | 737.46 | 626.6 | Upgrade
|
Income Tax Expense | 37.23 | 26.04 | 28.88 | -1.65 | -5.21 | Upgrade
|
Earnings From Continuing Operations | 192.52 | 205.02 | 128.87 | 739.12 | 631.81 | Upgrade
|
Net Income to Company | 192.52 | 205.02 | 128.87 | 739.12 | 631.81 | Upgrade
|
Minority Interest in Earnings | -41.74 | -51.84 | -22.83 | 0 | 0 | Upgrade
|
Net Income | 150.78 | 153.18 | 106.04 | 739.12 | 631.81 | Upgrade
|
Net Income to Common | 150.78 | 153.18 | 106.04 | 739.12 | 631.81 | Upgrade
|
Net Income Growth | -1.57% | 44.46% | -85.65% | 16.98% | 670.67% | Upgrade
|
Shares Outstanding (Basic) | 1,543 | 1,566 | 1,566 | 1,569 | 1,569 | Upgrade
|
Shares Outstanding (Diluted) | 1,543 | 1,566 | 1,566 | 1,569 | 1,569 | Upgrade
|
Shares Change (YoY) | -1.42% | -0.03% | -0.20% | -0.00% | 0.00% | Upgrade
|
EPS (Basic) | 0.10 | 0.10 | 0.07 | 0.47 | 0.40 | Upgrade
|
EPS (Diluted) | 0.10 | 0.10 | 0.07 | 0.47 | 0.40 | Upgrade
|
EPS Growth | -0.11% | 44.46% | -85.63% | 16.99% | 671.28% | Upgrade
|
Free Cash Flow | 261.93 | 163.73 | 216.77 | 25.92 | 70.33 | Upgrade
|
Free Cash Flow Per Share | 0.17 | 0.10 | 0.14 | 0.02 | 0.04 | Upgrade
|
Dividend Per Share | 0.092 | 0.089 | - | - | - | Upgrade
|
Dividend Growth | 3.00% | - | - | - | - | Upgrade
|
Gross Margin | 54.55% | 56.42% | 55.66% | 61.19% | 60.08% | Upgrade
|
Operating Margin | 22.63% | 26.54% | 18.29% | 17.34% | -9.98% | Upgrade
|
Profit Margin | 19.61% | 22.69% | 19.75% | 272.34% | 255.43% | Upgrade
|
Free Cash Flow Margin | 34.06% | 24.25% | 40.38% | 9.55% | 28.43% | Upgrade
|
EBITDA | 289.28 | 276.11 | 175.49 | 77.98 | 2.94 | Upgrade
|
EBITDA Margin | 37.62% | 40.90% | 32.69% | 28.73% | 1.19% | Upgrade
|
D&A For EBITDA | 115.28 | 96.97 | 77.32 | 30.91 | 27.63 | Upgrade
|
EBIT | 174.01 | 179.14 | 98.17 | 47.07 | -24.69 | Upgrade
|
EBIT Margin | 22.63% | 26.54% | 18.29% | 17.34% | -9.98% | Upgrade
|
Effective Tax Rate | 16.20% | 11.27% | 18.31% | - | - | Upgrade
|
Updated Sep 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.